Four-week histologic evaluation of grafted calvarial defects with adjunctive hyperbaric oxygen therapy in rats
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study was to characterize the healing in the grafted calvarial defects of rats after adjunctive hyperbaric oxygen therapy. Methods: Twenty-eight male Sprague-Dawley rats (body weight, 250–300 g) were randomly divided into two treatment groups: with hyperbaric oxygen therapy (HBO; n=14) and without HBO (NHBO; n=14). Each group was further subdivided according to the bone substitute applied: biphasic calcium phosphate (BCP; n=7) and surface-modified BCP (mBCP; n=7). The mBCP comprised BCP coated with Escherichia-coli-derived recombinant human bone morphogenetic protein-2 (ErhBMP-2) and epigallocatechin-3-gallate (EGCG). Two symmetrical circular defects (6-mm diameter) were created in the right and left parietal bones of each animal. One defect was assigned as a control defect and received no bone substitute, while the other defect was filled with either BCP or mBCP. The animals were allowed to heal for 4 weeks, during which those in the HBO group underwent 5 sessions of HBO. At 4 weeks, the animals were sacrificed, and the defects were harvested for histologic and histomorphometric analysis. Results: Well-maintained space was found in the grafted groups. Woven bone connected to and away from the defect margin was formed. More angiogenesis was found with HBO and EGCG/BMP-2 (P<0.05). None of the defects achieved complete defect closure. Increased new bone formation with HBO or EGCG/BMP-2 was evident in histologic evaluation, but it did not reach statistical significance in histometric analysis. A synergic effect between HBO and EGCG/BMP-2 was not found. Conclusions: Within the limitations of this study, the present findings indicate that adjunctive HBO and EGCG/BMP-2 could be beneficial for new bone formation in rat calvarial defects.
Abstract
Purpose: The aim of this study was to characterize the healing in the grafted calvarial defects of rats after adjunctive hyperbaric oxygen therapy. Methods: Twenty-eight male Sprague-Dawley rats (body weight, 250–300 g) were randomly divided into two treatment groups: with hyperbaric oxygen therapy (HBO; n=14) and without HBO (NHBO; n=14). Each group was further subdivided according to the bone substitute applied: biphasic calcium phosphate (BCP; n=7) and surface-modified BCP (mBCP; n=7). The mBCP comprised BCP coated with Escherichia-coli-derived recombinant human bone morphogenetic protein-2 (ErhBMP-2) and epigallocatechin-3-gallate (EGCG). Two symmetrical circular defects (6-mm diameter) were created in the right and left parietal bones of each animal. One defect was assigned as a control defect and received no bone substitute, while the other defect was filled with either BCP or mBCP. The animals were allowed to heal for 4 weeks, during which those in the HBO group underwent 5 sessions of HBO. At 4 weeks, the animals were sacrificed, and the defects were harvested for histologic and histomorphometric analysis. Results: Well-maintained space was found in the grafted groups. Woven bone connected to and away from the defect margin was formed. More angiogenesis was found with HBO and EGCG/BMP-2 (P<0.05). None of the defects achieved complete defect closure. Increased new bone formation with HBO or EGCG/BMP-2 was evident in histologic evaluation, but it did not reach statistical significance in histometric analysis. A synergic effect between HBO and EGCG/BMP-2 was not found. Conclusions: Within the limitations of this study, the present findings indicate that adjunctive HBO and EGCG/BMP-2 could be beneficial for new bone formation in rat calvarial defects.
참고문헌 (23)
- Hopf HW, "Hyperoxia and angiogenesis", Wound Repair Regen, 13, pp.558~564 (2005)
- Howard MA, "Oxygen and wound care: a review of current therapeutic modalities and future direction", Wound Repair Regen, 21, pp.503~511 (2013)
- Milovanova TN, "Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo", J Appl Physiol (1985), 106, pp.711~728 (2009)
- Jan AM, "Hyperbaric oxygen results in an increase in rabbit calvarial critical sized defects", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101, pp.144~149 (2006)
- Fok TC, "Hyperbaric oxygen results in increased vascular endothelial growth factor (VEGF) protein expression in rabbit calvarial critical-sized defects", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 105, pp.417~422 (2008)
- Jan A, "Effect of hyperbaric oxygen on grafted and nongrafted calvarial critical-sized defects", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107, pp.157~163 (2009)
- Muhonen A, "Osteodistraction of a previously irradiated mandible with or without adjunctive hyperbaric oxygenation: an experimental study in rabbits", Int J Oral Maxillofac Surg, 31, pp.519~524 (2002)
- Muhonen A, "Osteoblastic activity and neoangiogenesis in distracted bone of irradiated rabbit mandible with or without hyperbaric oxygen treatment", Int J Oral Maxillofac Surg, 33, pp.173~178 (2004)
- Laurencin C, "Bone graft substitutes", Expert Rev Med Devices, 3, pp.49~57 (2006)
- Palti A, "A concept for the treatment of various dental bone defects", Implant Dent, 11, pp.73~78 (2002)
- 최현민, "Improvement of osteogenic potential of biphasic calcium phosphate bone substitute coated with two concentrations of expressed recombinant human bone morphogenetic protein 2", Journal of Periodontal & Implant Science, 42(4), pp.119~126 (2012), 대한치주과학회[DOI]
- Kim MS, "Low-dose recombinant human bone morphogenetic protein-2 to enhance the osteogenic potential of the Schneiderian membrane in the early healing phase: in vitro and in vivo studies", J Oral Maxillofac Surg, 72, pp.1480~1494 (2014)
- 최현민, "Improvement of osteogenic potential of biphasic calcium phosphate bone substitute coated with synthetic cell binding peptide sequences", Journal of Periodontal & Implant Science, 42(5), pp.166~172 (2012), 대한치주과학회
- Shin YS, "The effects of ErhBMP-2-", EGCG-coated BCP bone substitute on dehiscence around dental implants in dogs, 2014, pp.20, 281~287
- Jin P, "Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study", Cell Tissue Res, 356, pp.381~390 (2014)
- Oka Y, "Tea polyphenols inhibit rat osteoclast formation and differentiation", J Pharmacol Sci, 118, pp.55~64 (2012)
- Sirin Y, "The influence of hyperbaric oxygen treatment on the healing of experimental defects filled with different bone graft substitutes", Int J Med Sci, 8, pp.114~125 (2011)
- Kaigler D, "Endothelial cell modulation of bone marrow stromal cell osteogenic potential", FASEB J, 19, pp.665~667 (2005)
- Wang DS, "Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells", Endocrinology, 138, pp.2953~2962 (1997)
- Bai Y, "Effects of combinations of BMP-2 with FGF-2 and", or VEGF on HUVECs angiogenesis in vitro and CAM angiogenesis in vivo, 2014, pp.356, 109~121
- Cai WX, "Effect of different rhBMP-2 and TG-VEGF ratios on the formation of heterotopic bone and neovessels", Biomed Res Int, 2014, pp.571510~ (2014)
- Lysdahl H, "Preconditioning human mesenchymal stem cells with a low concentration of BMP2 stimulates proliferation and osteogenic differentiation in vitro", Biores Open Access, 3, pp.278~285 (2014)
- Park JS, "Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1", 2, 2006, pp.29, 1247~1252